Hinge Health, Inc. (HNGE)
- Sector
- Health Care
- Last price
- $105.14
- As of
Kresmion compiles this page from HNGE's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Hinge Health, Inc. (HNGE): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-21.
See the full HNGE dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for HNGE on one page. Preview it with sample data, then open it live with a free account.
Preview the HNGE dossierActive signals for HNGE
- highinsider_cluster_sell
2 insiders at HNGE sold $25.5M this week
- highinsider_cluster_sell
3 insiders at HNGE sold $63.6M this week
- highCONSENSUS_BUY
6 tracked funds increased HNGE this 2026Q2, institutional consensus
- highinsider_cluster_sell
3 insiders at HNGE sold $49.6M this week
- highinsider_cluster_sell
2 insiders at HNGE sold $27.3M this week
FREE, NO ACCOUNT
Every signal on HNGE, as it fires
You are seeing 5 of 22 signals recorded on HNGE since 2026-05-29.
The five above landed across 3 days. The other 17 were recorded on 4 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in HNGE (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 433313103 · 2026Q2 | $150.1M | 0.11% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 433313103 · 2026Q2 | $63M | 0.09% | , |
| CITADEL ADVISORS LLCCUSIP 433313103 · 2026Q2 | $62.9M | 0.01% | , |
| Point72 Asset Management, L.P.CUSIP 433313103 · 2026Q2 | $22.3M | 0.02% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 433313103 · 2026Q2 | $16.2M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 433313103 · 2026Q2 | $722K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, HNGE
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
HNGE against its peers
HNGE's operating margin of -92.9% ranks in the 2nd percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | HNGE | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 588M USD | 1.9B USD | 6 | 25 |
| Gross margin | 79.6% | 57.6% | 91 | 16 |
| Operating margin | -92.9% | 8.5% | 2 | 23 |
| Net margin | -89.9% | 5.5% | 2 | 25 |
| Return on equity | -295.7% | 11.9% | 2 | 24 |
| P / E | n/a | 37.0x | n/a | 18 |
| 1 year | n/a | 16.1% | n/a | 24 |
Peers (25): MASI, HIMS, GKOS, PACS, ENSG, LNTH, CHE, MOH, BTSG, RDNT, PEN, EHC, DOCS, HAE, TFX, MMSI, WAY, OPCH, ITGR, LIVN, CRVL, NVST, IRTC, THC, GH. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (HNGE: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow HNGE on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to HNGE for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.